Breakout Labs funds Pareto Biotechnologies

In California, Thiel Foundation’s Breakout Labs selected Pareto Biotechnologies for funding. Breakout Labs is a philanthropic revolving fund financed by investor Peter Thiel to promote novel scientific ideas with promising commercial applications, awarding up to $350,000 to early-stage companies with cutting-edge technologies. 

Breakout Labs supports these companies in their quest to achieve specific milestones that are necessary to attract further support, thus bridging a critical funding gap on their path to commercialization. Pareto uses polyketide pathways in its biology platform to develop “designer molecules.”  In the near term, Pareto’s focus is on developing novel molecules for the cosmetics, flavors, and fragrances industries by 2015. Longer term, Pareto will create molecules that can be used in nutraceuticals, pharmaceuticals, and industrial commodities, such as plastics, resins, and adhesives. 

More on the story.